October 17, 2017 12:17 PM ET


Company Overview of BROS Ltd.

Company Overview

BROS Ltd. produces and supplies pharmaceuticals. The company offers antibiotics, anti-hypertensive, anti-fungal, analgesics, vasodilators, anxiolytic, and antidepressants. Additionally, its products include tablets and capsules, creams, ointments, gels, suppositories, oral drops, syrups, suspensions, and dry powders. The company provides its products under YOKEL, CONSTILAX, FLEXELITE, SOTOMYCIN, CEVIGEN, and NEVRORESTOL brand names. BROS Ltd was founded in 1970 and is based in Athens, Greece.

15, Galinis and Avis street

New Kifissia



Founded in 1970


30 210 80 72 450


30 210 62 02 211

Key Executives for BROS Ltd.

Managing Director
Scientific Manager
Compensation as of Fiscal Year 2017.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BROS Ltd., please visit www.brosltd.gr. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.